In a study to evaluate the clinical significance of anti-CRT antibodies using the serum of patients with IBD, Watanabe et al. found the mean titer of anti-CRT antibodies was higher in patients with CD than in healthy individuals. The gene discussed is CALR; the disease is inflammatory bowel disease.